Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 7INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 3214Carcinoma, Non-Small-Cell Lung 2727Breast Neoplasms 2550Colorectal Neoplasms 1461Prostatic Neoplasms 1307Neoplasm Metastasis 1300Multiple Myeloma 1112Melanoma 1103Ovarian Neoplasms 1006Lung Neoplasms 944Recurrence 924Leukemia, Myeloid, Acute 879Pancreatic Neoplasms 832Lymphoma, Non-Hodgkin 767Lymphoma 713Stomach Neoplasms 692Carcinoma, Renal Cell 660Carcinoma, Hepatocellular 647Leukemia, Lymphocytic, Chronic, B-Cell 560Squamous Cell Carcinoma of Head and Neck 550Lymphoma, Follicular 515Head and Neck Neoplasms 490Glioblastoma 472Small Cell Lung Carcinoma 447Lymphoma, Large B-Cell, Diffuse 440Triple Negative Breast Neoplasms 435Advanced Solid Tumors 432Leukemia 426Uterine Cervical Neoplasms 420Urinary Bladder Neoplasms 405

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Eye Diseases × Clear all
NCT05013944 2024-01-30

AnovaOS Network Powered Patient Registry

Anova Enterprises, Inc

Recruiting
100,000 enrolled

Congenital Abnormalities, Urogenital Diseases, Mental Disorders, Chromosome Aberrations, Communicable Diseases, Digestive System Diseases, Ear Diseases, Eye Diseases, Metabolic Diseases, Neoplasms, Nervous System Diseases, Poisoning, Respiration Disorders, Skin Diseases, Wounds and Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡